Stock Events

Stock Events

Karyopharm Therapeutics (KPTI) Q1 2025 Earnings

19FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-3.92

-2.68

-1.44

-0.2

Details

Expected EPS

-3.921429

Actual EPS

-3.6

Surprise EPS

0.32

Surprise Percent

+8.2%

Description

Karyopharm Therapeutics (KPTI) has reported earnings of -3.6 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.